Stocks to Buy

Identifying winning stocks requires more than scanning headlines. InvestorPlace analysts focus on long-term themes, market timing, and structural shifts shaping where capital is flowing next, highlighting stocks positioned to benefit from those trends.

5 Insurance Stocks to Buy Now

This week, five insurance stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

5 Semiconductor Stocks to Buy Now

This week, five semiconductor stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

3 Commercial Services Stocks to Buy Now

Three commercial services stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

5 Stocks With Great Earnings Momentum — KNSY FB GIB REGI STV

This week, these five stocks have the best ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader.

5 Biotech Stocks With Big Catalysts on the Horizon

Announcements from, or about, these biotech stocks could greatly inflate their values ... or completely deflate them.

Intel Earnings: Hit or Miss, INTC Is a Buy

Analysts appear a little bearish heading into tomorrow's Intel earnings report, but long-term drivers point in favor of INTC stock.

Crude-By-Rail Is Here To Stay – 3 Best Railroad Stocks to Play It

Despite recent accidents, crude-by-rail volumes are surging ... and railroad stocks like CNI, CP and TRN are the best way to play that surge.

ICPT: Time to Catch a Rising Star With Intercept Stock?

It's never too late to invest in a long-term winner, and pharmaceutical player Intercept is on a long-term run. Here's why you should join the race...

2 Global Value Stocks to Buy

One model of profitability and value can help investors search across the globe for attractive equities. Here are two such value stocks to buy.

ACT: Actavis’s Growth Potential Anything But Generic

Pharmaceutical company Actavis is at the forefront on the production of biologic drugs, and stands to profit from them well into the future. It's a buy!

LUV: Southwest Airlines is Set To Soar Into the Future

The airline industry is starting to look up, and nobody may be in a better position to soar as Southwest Airlines. Find out why it's a buy here...

5 Stocks With Prime Earnings Growth — OME PHX LRCX ITG PHM

This week, these five stocks have the best ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader.

5 Electric Vehicle Stocks to Buy Now … That Aren’t Tesla

Tesla has become the iconic name in the electric vehicle world, but there are lots of other stocks to buy in the EV arena. Here are five of the hottest.

5 Stocks With Superb Cash Flow — YONG ZA GURE REGI CHA

This week, these five stocks have the best ratings in Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.

3 Stocks to Buy in January

While the general market outlook appears pretty grim at present, I'm seeing a few stocks to buy in the biotech and mining industries.

Micron Looks to Continue It’s Growth Momentum – MU

Micron stock weathered a little bit of a storm at the end of 2013, and the early indications for 2014 are the stock is a long-term keeper in your portfolio

10 Medical Devices Stocks to Buy Now

This week, 10 medical devices stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

6 Mortgage Stocks to Buy Now

The grades of six mortgage stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.

4 Aerospace and Defense Stocks to Buy Now

This week, four aerospace and defense stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").